Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient.

Kamar, Nassim

Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. [electronic resource] - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Aug 2010 - 2792-5 p. digital

Publication Type: Case Reports; Journal Article

1460-2385

10.1093/ndt/gfq282 doi


Adult
Antiviral Agents--therapeutic use
Chronic Disease
Dose-Response Relationship, Drug
Hepatitis E--drug therapy
Hepatitis E virus
Humans
Immunosuppressive Agents--therapeutic use
Interferon alpha-2
Interferon-alpha--therapeutic use
Kidney Failure, Chronic--therapy
Kidney Transplantation--immunology
Male
Nephritis, Hereditary--surgery
Opportunistic Infections--drug therapy
Polyethylene Glycols--therapeutic use
Recombinant Proteins
Renal Dialysis
Treatment Outcome